Sponsor
Bharat Biotech in-licences GSK's Shigella vaccine candidate
Posted
Bharat Biotech has in-licensed GSK's Shigella vaccine candidate, altSonflex1-2-3, aimed at combating Shigellosis in young children in low- and middle-income countries. Following promising early-stage trials by GSK, Bharat Biotech will advance the vaccine through Phase-III trials, regulatory processes, and large-scale production. This collaboration strengthens Bharat Biotech's portfolio of vaccines against diarrheal infections.
Căutare
Categorii
- National
- International
- Business
- Technology
- Health
- Educaţie
- Sports
- Entertainment
- Travel
- Environment
- Science
- Law
- Agriculture
- Real Estate
- Opinion
- Religion
- Weather
- Automotive
- Social Issues
- Culture
- Sci-Fi & Future
Citeste mai mult
Torii's Head Chef shares SRK-AbRam’s favorite dish
Torii, Gauri Khan's Mumbai restaurant, is a celebrity hotspot with a secret entrance for the Khan...
Madhyabindu Provincial Hospital upgraded to 100-bed facility
NAWALPARASI: Madhyabindu Provincial Hospital, located in Kawasoti-16, Danda of Nawalparasi...
Wind energy centre of Atma Nirbhar Bharat: India becomes 3rd largest maker of renewable energy; wind capacity hits 51.5 GW in a decade
Union Minister Pralhad Joshi emphasized wind energy's crucial role in India's clean energy goals...